Search - tctmd.com

Displaying 201 - 220 of 263

Sort: Relevancy | Date

News Daily News

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

Yael L. Maxwell

January 28, 2015

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

News Conference News TCT 2014

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

September 19, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

Study Suggests Noncardiac Surgery Can Be Safe as Early as 3 Months After PCI

Yael L. Maxwell

August 20, 2014

News Daily News

对STEMI患者使用网膜支架安全，但是TLR、TVR风险比BMS高

July 08, 2014

News Daily News

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

July 08, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

Presentation TCT 2013

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Presenter: Gunnar Tepe

October 31, 2013

Presentation TCT 2013

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Presenter: Clemens von Birgelen

October 28, 2013

Presentation TCT 2013

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Presenter: Lisette Okkels Jensen

October 28, 2013

Presentation TCT 2013

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

Presenter: Peter Smits

October 28, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

Advertisement

TE-PROVE: European Postapproval Study of PES Shows Safety in All-Comers

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

Bioabsorbable Polymer DES Represent Evolution to Stenting Platform

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Study Suggests Noncardiac Surgery Can Be Safe as Early as 3 Months After PCI

对STEMI患者使用网膜支架安全，但是TLR、TVR风险比BMS高

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future

Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future

Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content